Year: 2022

Uncategorized

COVID Treatment Update – Bebtelovimab No Longer Authorized

Read Time: 1 min

The FDA announced that bebtelovimab is not authorized in the United States effective immediately due to sustained trends of increasing prevalence of resistant subvariants. Kettering Health will remove bebtelovimab from the COVID Outpatient Referral Form accordingly. Patients who were scheduled for bebtelovimab are being reviewed for alternate treatment options and will be notified. The COVID…

1 2 3 4 29
ABOUT K-NEWS

Kettering Health employees’ hub for system updates, stories about our people, events, and more.